BJCT-BIOJECT-needle less injection product Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : BJCT-BIOJECT-needle less injection product

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: dorothy sg who wrote ()	8/4/1997 1:48:00 PM
From: geewiz	of 534

Hi NI, There is indeed an analyst following the company. He is Frank Lyel, MD of some San Francisco Company. He is projecting earnings of $0.31 in 00; can't imagine forcasting that far out. A lot of the six page report I've heard before, but there are some nuggets. For one BJCT is in phase I/II trials for an injectable DNA vac. with an undisclosed company. As for the $700,000 from the WMT deal, it sounds a little high. I figure 400 locations, 3 days each, 100 injections per day, = 120,000 injections; I don't know what the customer pays, but if its' $3 then that's not even half! But it should at least match or exceed recurring revenue. Call Bev Allen in IR for a faxed copy of the research report; I haven't read all of it yet. best, art

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next